Comprehensive Clinical, Diagnostic, and In Silico Assessment of a Novel 1p36.33p36.32 Copy Number Variant
Journal of Cellular and Molecular Medicine · 2026-02 · 30 (4)
DOI: 10.1111/jcmm.71079 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 25.02.2026. Verfasst von Atieh Eslahi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: DNA Copy Number Variations, Chromosomes, Human, Pair 1, Developmental Disabilities. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Clinical manifestations of 1p36.33 duplications vary depending on duplication size. This region is prone to copy number variants associated with diverse phenotypes. We report a novel 1p36.33p36.32 duplication in a patient with developmental delay and facial dysmorphism. The causative duplication was detected by whole‐genome Oligo‐array CGH and confirmed by real‐time PCR. Integrative bioinformatic analyses—including network analysis, phenotype‐driven gene prioritisation, and dosage sensitivity assessment—were performed to explore the molecular basis of the phenotype; we used integrative bioinformatic analyses, including network analysis, phenotype‐driven gene prioritisation, and dosage sensitivity assessment. Assessment of a child with tonic seizures, developmental delay, and dysmorphic facial traits revealed a 2.3 MB gain in the 1p36.33p36.32 region (nucleotide 898,721 to 3,153,945) through array CGH. Bioinformatic analyses identified several candidate genes, including GABRD , DVL1 , and GNB1 , which are implicated in neurodevelopmental and congenital disorders. Pathway enrichment analysis revealed significant involvement of the ‘1P36 Copy Number Variation Syndrome’ pathway. This case expands the phenotypic spectrum of 1p36 duplications and highlights the importance of integrating clinical, genomic, and bioinformatic data for accurate interpretation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Genetics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- Rare Pediatric Neurological Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
- Genetic Foundation of Khorasan Razavi, Mashhad, Iran.
- Department of Pediatrics, Dr Sheikh Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
- Neuroscience Research Centre, Mashhad University of Medical Sciences, Mashhad, Iran.
- Blood Transfusion Organization, Mashhad, Iran.
ORCID-Profile: Bita Barazandeh Shirvan
Zitieren
APA
Eslahi, A., Kahaei, M. S., Shirvan, B. B., Alerasool, M., Tabarestani, S., Rezaie, R., Hashemi, N., Akhondian, J., Arabi, M., Ebrahimzadeh, F., Toosi, M. B., & Mojarrad, M. (2026). Comprehensive Clinical, Diagnostic, and In Silico Assessment of a Novel 1p36.33p36.32 Copy Number Variant. Journal of Cellular and Molecular Medicine, 30(4). https://doi.org/10.1111/jcmm.71079
Vancouver
Eslahi A, Kahaei MS, Shirvan BB, Alerasool M, Tabarestani S, Rezaie R, et al. Comprehensive Clinical, Diagnostic, and In Silico Assessment of a Novel 1p36.33p36.32 Copy Number Variant. Journal of Cellular and Molecular Medicine. 2026;30(4). doi:10.1111/jcmm.71079
BibTeX
@article{Eslahi2026,
author = {Eslahi, Atieh and Kahaei, Mir Salar and Shirvan, Bita Barazandeh and Alerasool, Masoome and Tabarestani, Sepideh and Rezaie, Razie and Hashemi, Narges and Akhondian, Javad and Arabi, Mobina and Ebrahimzadeh, Farnoosh and Toosi, Mehran Beiraghi and Mojarrad, Majid},
title = {Comprehensive Clinical, Diagnostic, and In Silico Assessment of a Novel 1p36.33p36.32 Copy Number Variant},
journal = {Journal of Cellular and Molecular Medicine},
year = {2026},
volume = {30},
number = {4},
doi = {10.1111/jcmm.71079}
}
EUVIMED